Food Insecurity As a Determinant of Poorer Health-Related Quality of Life Among Patients with Chronic Conditions in the United States
Speaker(s)
Krupsky K1, Way N2, Drakeley S3, Eslamimehr S3
1Oracle Life Sciences, Royal Oak, MI, USA, 2Oracle Life Sciences, Santa Barbara, CA, USA, 3Oracle Life Sciences, Austin, TX, USA
Presentation Documents
OBJECTIVES: Food insecurity (FI), defined as inadequate access to food needed for healthy and active living due to insufficient resources, affected 12.8% of United States (US) households in 2022. The deleterious effects of FI on health and well-being are well-documented. Yet, this important social determinant of health is underrepresented in patient-reported outcomes research. We evaluated associations between FI and health-related quality of life (HRQoL) among patients with prevalent chronic conditions.
METHODS: Data from the 2023 US National Health and Wellness Survey were used to construct cohorts of patients with heart disease (HD; N=6,557), cancer (N=7,910), chronic lung disease (N=8,084), stroke (N=1,566), depression (N=16,299), type 2 diabetes (T2D; N=6,341), and chronic kidney disease (N=1,705). FI was evaluated with the Hunger Vital SignTM 2-item screener. HRQoL was measured with the RAND-36 (Physical Health Composite (PHC); Mental Health Composite (MHC) T scores) and EQ-5D index scores. Linear regression models estimated mean HRQoL scores, relative to FI, adjusting for race/ethnicity, income-to-poverty ratio, sex, marital status, education, smoking status, alcohol use, Charlson Comorbidity Index, and age. The extent to which FI improved the predictive validity of models was evaluated with the change in R2 attributed to FI.
RESULTS: FI was related to worse HRQoL across all cohorts (ps<0.001). The largest differences between patients who were food secure vs food insecure were observed in the T2D (PHC: 41.9 vs 35.7, ΔR2=3.9%; MHC: 45.2 vs 36.8, ΔR2=5.9%; EQ-5D: 0.778 vs 0.680, ΔR2=4.2%), cancer (PHC: 45.5 vs 37.8, ΔR2=4.1%; MHC: 48.1 vs 39.2, ΔR2=4.8%; EQ-5D: 0.811 vs 0.698, ΔR2=4.6%), and HD (PHC: 40.9 vs 34.7, ΔR2=3.7%; MHC: 44.3 vs 36.6, ΔR2=4.7%; EQ-5D: 0.763 vs 0.671, ΔR2=3.7%) cohorts.
CONCLUSIONS: Our results show several therapeutic areas where FI is associated with health outcomes, and suggests type 2 diabetes, cancer, and heart disease may be conditions where improvements to food security is of utmost importance.
Code
PCR190
Topic
Epidemiology & Public Health, Health Policy & Regulatory, Patient-Centered Research
Topic Subcategory
Health Disparities & Equity, Patient-reported Outcomes & Quality of Life Outcomes, Public Health
Disease
Cardiovascular Disorders (including MI, Stroke, Circulatory), Mental Health (including addition), No Additional Disease & Conditions/Specialized Treatment Areas, Oncology, Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)